Bista Pawan, Imlach Wendy L
Department of Physiology & Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia.
Medicines (Basel). 2019 Aug 22;6(3):91. doi: 10.3390/medicines6030091.
Trigeminal neuropathic pain is a chronic pain condition caused by damage or inflammation of the trigeminal nerve or its branches, with both peripheral and central nervous system dysfunction contributing to the disorder. Trigeminal pain conditions present with diagnostic and therapeutic challenges to healthcare providers and often require multiple therapeutic approaches for pain reduction. This review will provide the overview of pathophysiology in peripheral and central nociceptive circuits that are involved in neuropathic pain conditions involving the trigeminal nerve and the current therapeutics that are used to treat these disorders. Recent advances in treatment of trigeminal pain, including novel therapeutics that target ion channels and receptors, gene therapy and monoclonal antibodies that have shown great promise in preclinical studies and clinical trials will also be described.
三叉神经病理性疼痛是一种由三叉神经或其分支的损伤或炎症引起的慢性疼痛病症,周围神经系统和中枢神经系统功能障碍均导致该病症。三叉神经疼痛病症给医疗服务提供者带来了诊断和治疗方面的挑战,通常需要多种治疗方法来减轻疼痛。本综述将概述参与三叉神经相关神经性疼痛病症的外周和中枢伤害性感受回路的病理生理学,以及用于治疗这些病症的当前疗法。还将描述三叉神经疼痛治疗的最新进展,包括靶向离子通道和受体的新型疗法、在临床前研究和临床试验中显示出巨大潜力的基因疗法和单克隆抗体。